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key role for DAG lipase activity in the control of
 
axonal growth and guidance in vitro and in vivo has
been established. For example, DAG lipase activity
is required for FGF-stimulated calcium inﬂux into neuronal
growth cones, and this response is both necessary and
sufﬁcient for an axonal growth response. The mechanism
that couples the hydrolysis of DAG to the calcium response
is not known. The initial hydrolysis of DAG at the sn-1
position (by DAG lipase) will generate 2-arachidonylglycerol,
and this molecule is well established as an endogenous
cannabinoid receptor agonist in the brain. In the present
A
 
paper, we show that in rat cerebellar granule neurons, CB1
cannabinoid receptor antagonists inhibit axonal growth
responses stimulated by N-cadherin and FGF2. Furthermore,
three CB1 receptor agonists mimic the N-cadherin/FGF2
response at a step downstream from FGF receptor activation,
but upstream from calcium inﬂux into cells. In contrast, we
could ﬁnd no evidence for the CB1 receptor coupling the
TrkB neurotrophin receptor to an axonal growth response in
the same neurons. The observation that the CB1 receptor
can couple the activated FGF receptor to an axonal growth
response raises novel therapeutic opportunities.
 
Introduction
 
Over the past 10 years or so, numerous molecules that can
promote and/or inhibit axonal growth have been identified,
and an emerging theme is that these molecules function by
activating a limited number of signal transduction cascades
in growth cones (Tessier-Lavigne and Goodman, 1996;
Doherty et al., 2000). NCAM, N-cadherin, and L1 are cell
adhesion molecules (CAMs)* that promote axonal growth
during development, and have a function in synaptic plastic-
ity in the adult (Walsh and Doherty, 1997). Their ability to
activate an FGF receptor–signaling cascade in growth cones
is required for, and sufficient to explain, their positive effects
on growth cone motility (Williams et al., 1994a; Saffell et
al., 1997). The proximal steps in the FGF receptor signal
transduction cascade involve activation of phospholipase C
 
 
 
to generate DAG (Hall et al., 1996), with the subsequent
hydrolysis of DAG by an as yet uncharacterized DAG lipase
coupling the pathway to an axonal growth response by stim-
ulating calcium influx into the growth cone through N- and
L-type calcium channels (Doherty et al., 1991a, 1995;
Williams et al., 1994b, 1994c; Lom et al., 1998). Interest-
ingly, under normal conditions, the calcium changes are not
global, but instead are highly localized to the submembranous
region of the growth cone (Archer et al., 1999; Chadborn et
al., 2002). This is likely to be a very important feature of the
pathway, as this type of highly localized change in calcium
in growth cones is sufficient to induce the formation of new
filopodia in vivo (Lau et al., 1999), and can also induce
growth cone turning responses in vitro (Zheng, 2000). A
key role for DAG lipase activity in the control of axonal
growth and guidance in vivo has also been established (Brittis
et al., 1996; Lom et al., 1998). Interestingly, the ability of
N-cadherin to directly interact with the FGFR has also been
implicated in tumor cell metastasis (Suyama et al., 2002),
and N-cadherin–stimulated increases in tumor cell migra-
tion are also dependent on DAG lipase activity (Nieman et
al., 1999).
 
The mechanism that couples the hydrolysis of DAG to
the calcium response in neurons is not known. The canonical
pathway would involve the synthesis of two key second
messengers in neurons. The initial hydrolysis of DAG at
the sn-1 position (by DAG lipase) will generate 2-arachidonyl-
glycerol (2-AG), with the subsequent hydrolysis of 2-AG
generating arachidonic acid. At first sight, arachidonic acid
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appeared to be the best candidate for the “instructive” sig-
nal for axonal growth in the CAM/FGF receptor pathway,
as the direct application of arachidonic acid to primary
neurons fully mimics the neurite outgrowth response
stimulated by FGF2 and the aforementioned CAMs (Wil-
liams et al., 1994a, 1994c). However, arachidonic acid
can stimulate the accumulation of 2-AG in cells (Ueda et
al., 2000), and this raises the possibility that it might be
2-AG that normally couples the FGF receptor signaling
cascade to the calcium response. Interestingly, 2-AG is a
ligand for the CB1 and CB2 cannabinoid receptors (Di
Marzo et al., 1998), and in some instances cannabinoid
receptors have been shown to positively couple with cal-
cium channels (Okada et al., 1992; Sugiura et al., 1996;
Rubovitch et al., 2002). Based on these observations, we
tested for “cross-talk” between the FGF receptor and en-
docannabinoid signaling systems. Now, we provide com-
pelling evidence that signaling via the CB1 receptor is not
only required for, but can also mediate, the neurite out-
growth response stimulated by N-cadherin and FGF2,
and that it does so by coupling DAG hydrolysis to a sig-
naling cascade that depends upon calcium influx into neu-
rons via both N- and L-type calcium channels.
 
Results and discussion
 
CB1 receptor antagonists inhibit the neurite 
outgrowth response stimulated by N-cadherin 
and FGF2, but not BDNF
 
In the adult brain, cannabinoid receptor agonists released
from postsynaptic neurons act as retrograde messengers to
suppress neurotransmitter release from the presynaptic
axon. The effect is largely mediated by the CB1 receptor,
and involves the coupling of a pertussis toxin–sensitive G
protein to inhibition of calcium influx through N-type cal-
cium channels (for review see Wilson and Nicoll, 2002).
However, the CB1 receptor is also expressed in the embry-
onic nervous system (Buckley et al., 1998; Berrendero et
al., 1999), and this suggests additional functions for the
CB1 receptor during development.
When postnatal cerebellar neurons are cultured over
monolayers of transfected 3T3 cells that express physiolog-
ical levels of N-cadherin, N-cadherin promotes neurite
Figure 1. CB1 receptor expression on cerebellar neurons. Cerebellar 
neurons were cultured overnight in media containing 5 ng/ml FGF2 
before being fixed and stained for the CB1 receptor (see Materials 
and methods). The above picture shows a representative example of 
a stained cerebellar neuron. The inset shows an individual growth 
cone at higher magnification. The bar is 10  m relative to the larger 
image, and 5  m relative to the inset. No staining was seen when 
the primary antibody was omitted.
Figure 2. CB1 antagonists inhibit N-cadherin and FGF2 responses. 
(A) Cerebellar neurons were cultured on 3T3 monolayers or 
N-cadherin–expressing monolayers in control media or media 
supplemented with 1  M AM 251 or AM 281 as indicated. (B) Cer-
ebellar neurons were cultured over 3T3 cell monolayers in control 
media or media supplemented with 5 ng/ml FGF2 in the presence of 
increasing concentrations of AM 251 as indicated. (C and D) Cere-
bellar neurons were cultured over 3T3 monolayers in control media 
or media supplemented with 5 ng/ml FGF2 or 5 ng/ml BDNF in the 
presence of 1  M AM 251, AM 281, or AM 630 as indicated. In 
each instance, the cultures were fixed after 18 h, and the length of 
the longest neurite per cell was determined from  120 neurons. 
The results show absolute neurite length. In A and B, results are 
shown for an individual representative experiment. In C and D, 
results were pooled from the given number of independent experi-
ments. Bars show the SEM.T
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outgrowth via a mechanism that requires activation of a
neuronal FGF receptor signal transduction cascade (Wil-
liams et al., 2001). Given the requirement of DAG lipase
activity for the axonal growth response, and considering
that the hydrolysis of DAG will generate the CB1 agonist
2-AG, we decided to test whether CB1 function was re-
quired for the N-cadherin response. In this context, there
is ample evidence that cultured cerebellar neurons express
the CB1 receptor on cell bodies and neurites (for review
see Nogueron et al., 2001), and we have extended this ob-
servation to cerebellar growth cones (Fig. 1). Our results
show that two independent CB1 antagonists (AM 251 and
AM 281) completely inhibit the N-cadherin component of
the neurite outgrowth response (Fig. 2 A). If the CB1 an-
tagonists are acting at a step downstream from the FGF re-
ceptor, they should also inhibit the neurite outgrowth
response stimulated by FGF2. Fig. 2 B shows a representa-
tive example of an experiment where various doses of AM
251 were tested for their ability to inhibit the response
stimulated by 5 ng/ml FGF2. A substantial inhibition
(
 
 
 
80%) of the response can be seen at an AM 251 concen-
tration of 0.2 
 
 
 
M, with a complete inhibition found at
1 
 
 
 
M. A series of pooled experiments show that at 1 
 
 
 
M,
both AM 251 and AM 281 completely inhibit the FGF2
response (Fig. 2 C). In contrast, a specific CB2 receptor
antagonist (AM 630) had no effect on the FGF2 response
(Fig. 2 C). BDNF stimulates axonal growth by activating
the TrkB receptor tyrosine kinase, and as this response
does not depend on the hydrolysis of DAG (Lom et al.,
1998), there is no obvious basis for postulating a role for
the endocannabinoid signaling in the response. In agree-
ment, AM 251 and AM 281 did not inhibit the neurite
outgrowth response stimulated by BDNF (Fig. 2 D).
 
Activation of the CB1 receptor stimulates 
neurite outgrowth
 
Next, we determined whether activation of the CB1 recep-
tor could mimic the FGF2 response, and whether this re-
quires FGF receptor function. When neurons were treated
with 5 ng/ml FGF2 or 0.2 
 
 
 
M of the CB1 agonist WIN
55,212–2, there was a clear increase in neurite outgrowth
with no obvious difference in the nature of the neuronal
response stimulated by these agents (Fig. 3). In total, we
found that three CB1 receptor agonists (WIN 55,212–2,
ACEA, and noladin ether [NA]) stimulated neurite out-
growth in a dose-dependent manner with maximal re-
sponses found in the low 
 
 
 
M range (Fig. 4 A). Again, neu-
rons treated with the CB1 agonists were not obviously
different from those treated with FGF2 or N-cadherin.
The responses to all three CB1 agonists were fully inhib-
ited by AM 251 and AM 281 (Fig. 4 B), confirming that
they reflect activation of the CB1 receptor. A specific FGF
receptor inhibitor (PD 173074) that fully inhibits the
FGF2 and N-cadherin responses (Skaper et al., 2000; Wil-
liams et al., 2001) had no effect on the responses stimu-
lated by all three CB1 agonists (Fig. 4 B), and this dem-
onstrates that CB1 function is downstream from FGF
receptor activation. Direct application of arachidonic acid
to primary neurons can also fully mimic the neurite out-
growth response stimulated by CAMs and FGF2 at a site
downstream from FGF receptor activation, but upstream
from calcium influx into growth cones (Williams et al.,
1994a, 1994c). The arachidonic acid response is also fully
inhibited by the two CB1 receptor antagonists, demon-
strating that arachidonic acid also acts upstream of the
CB1 receptor, possibly by stimulating 2-AG synthesis in
cells (unpublished data).
Figure 3. The effect of FGF2 and CB1 agonists on neuronal morphology. Cerebellar neurons were cultured overnight on 3T3 cell monolayers 
in control media (a–d) containing 5 ng/ml FGF2 (e–h) or media containing 0.2  M WIN 55,212–2 (i–l) before being fixed and stained for GAP-43. 
Representative examples of neurite-bearing cells are shown.T
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N- and L-type calcium channel antagonists inhibit the 
neurite outgrowth response stimulated by CB1 agonists
 
DAG hydrolysis couples the FGF receptor pathway to an ax-
onal growth response by stimulating calcium influx into the
growth cone through N- and L-type calcium channels (Wil-
liams et al., 1994b, 1994c; Archer et al., 1999; for review see
Doherty et al., 2000). If endocannabinoid signaling medi-
ates this response, then L- and N-type calcium channel an-
tagonists should inhibit the response to the CB1 agonists, as
these agents inhibit the FGF2 response from all tested neu-
rons, including rat cerebellar granule cells (Williams et al.,
1994b). To test this, we cultured neurons with the various
CB1 receptor agonists in media further supplemented with
an L-type calcium channel antagonist (diltiazem at 10 
 
 
 
M),
an N-type calcium channel antagonist (
 
 
 
-conotoxin, 250
nM), or a combination of both. The CB1 agonists failed to
elicit a neurite outgrowth response when N- and L-type cal-
cium channels were simultaneously inhibited, and they only
elicited small responses when individual channels were
blocked (Fig. 5). Thus, we can conclude that the CB1 ago-
nists promote neurite outgrowth via a mechanism that re-
quires calcium influx into neurons through N- and L-type
calcium channels. Interestingly, the neurite outgrowth re-
sponse stimulated by BDNF was completely unaffected by
the calcium channel antagonists (Fig. 5), and this further
demonstrates that two receptor tyrosine kinases (the FGF re-
ceptor and TrkB receptor) use different signal transduction
cascades to couple to an axonal growth response in cerebellar
neurons.
At first sight, calcium influx into neurons might seem an
unlikely mechanism for the CB1 agonist driven neurite out-
growth response, given the paucity of data in the literature
reporting positive effects of cannabinoid agonists on calcium
levels in cells. However, it should be noted that under nor-
mal conditions, the calcium changes induced by CAMs and
FGF2 are not detectable by conventional imaging, as they
are highly localized to the submembranous region of the
growth cone (Archer et al., 1999; Chadborn et al., 2002).
Furthermore, the notion that cannabinoid receptor activa-
tion can have positive effects on calcium influx is not with-
out precedence, as it has been shown that the CB1 receptor
can positively modulate L-type calcium channels in a neu-
Figure 4. CB1 receptor agonists stimulate neurite outgrowth. 
(A) Cerebellar neurons were cultured on 3T3 monolayers in control 
media or media supplemented with the given concentrations of 
three CB1 receptor agonists (WIN 55,212–2, ACEA, and NA) as 
indicated. In each instance, the cultures were fixed after 18 h, and 
the length of the longest neurite per cell was determined from  120 
neurons. The results are from a single representative experiment, 
and each value shows the percent increase in mean neurite length 
relative to control media. Bars show the SEM. (B) Cerebellar neurons 
were cultured on 3T3 monolayers in control media or media 
supplemented with 0.2  M WIN 55,212–2 (WIN), 1  M ACEA, or 1 
 M NA, as indicated. The experiments were done in control media 
and media supplemented with 500 nM PD 173074, 1  M AM 251, 
or 1  M AM 281. In each instance, the cultures were fixed after 18 
h, and the length of the longest neurite per cell was determined 
from  120 neurons. The results are pooled from three independent 
experiments and show the percent increase in mean neurite length 
relative to control media. Bars show the SEM.
Figure 5. The response to the CB1 agonists requires calcium influx 
into neurons. Cerebellar neurons were cultured on 3T3 monolayers 
in control media or media supplemented with 0.2  M WIN 55,212–2 
(WIN), 1  M ACEA, 1  M NA, or 5 ng/ml BDNF as indicated. The 
experiments were done in control media (SATO supplemented with 
2% FCS) or media further supplemented with 250 nM  -conotoxin, 
and/or 10  M diltiazem as indicated. In each instance, the cultures 
were fixed after 18 h, and the length of the longest neurite per cell 
was determined from  120 neurons. The results are pooled from 
three independent experiments and show the percent increase in 
mean neurite length relative to control media. Bars show the SEM.T
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ronal cell line (Sugiura et al., 1996; Rubovitch et al., 2002).
In addition, low concentrations of the natural cannabinoid
receptor agonist 
 
 
 
9
 
-THC enhance K
 
 
 
 induced increases in
calcium levels in cells (Okada et al., 1992). The stimulation
of calcium influx into cells by cannabinoid receptor agonists
is insensitive to pertussis toxin (Sugiura et al., 1996; Rubo-
vitch et al., 2002), with the available evidence suggesting
that it might be mediated by the now well-established stimu-
latory effects of cannabinoids on adenylate cyclase (Glass
and Felder, 1997; Felder et al., 1998; Calandra et al., 1999;
Ishii and Chun, 2002). Interestingly, we have found that
pertussis toxin does not inhibit the cannabinoid agonist re-
sponses reported in this study (unpublished data).
Biphasic responses to cannabinoids have been noted in
biochemical, physiological, and behavioral studies (Okada et
al., 1992; Glass and Felder, 1997; Sulcova et al., 1998). The
data have been interpreted as evidence for the concomitant
activation of two parallel pathways by the activated CB1 re-
ceptor, namely a stimulatory pertussis toxin–insensitive path-
way, and an inhibitory pertussis toxin–sensitive pathway. An
analogous situation might explain the biphasic nature of the
neurite outgrowth response to FGF2 and arachidonic acid,
and the fact that in some circumstances activation of the FGF
receptor can inhibit axonal growth (Williams et al., 1994a,
1994c, 1995). In this scheme, the more classical CB1-medi-
ated inhibition of calcium channels (Caulfield and Brown,
1992; Mackie and Hille, 1992) might account for the desen-
sitization/inhibitory component of the response.
In summary, to our knowledge, this is the first explicit
demonstration of cross-talk between a neuronal receptor ty-
rosine kinase and the endocannabinoid system. This work
also suggests that the emerging roles for adhesion molecules
such as N-cadherin in synaptic plasticity in the adult (for re-
view see Goda, 2002; Togashi et al., 2002) might be consid-
ered alongside their ability to activate the endocannabinoid
signaling system.
 
Materials and methods
 
Neurite outgrowth assays and immunocytochemistry
 
Cerebellar neurons were cultured over monolayers of parental 3T3 cells or
an established transfected 3T3 cell line that expresses physiological levels of
chick N-cadherin (the LK8 cell line; for review see Doherty et al., 1991b) as
described previously (Williams et al., 1994a). For establishment of the co-
cultures, 
 
 
 
80,000 monolayer cells were plated into individual chambers of
an eight-chamber tissue culture slide (precoated with poly-
 
L
 
-lysine and fi-
bronectin) and maintained overnight in DME/10% FCS. The medium was
removed, and 
 
 
 
6,000 dissociated cerebellar neurons (taken from postnatal
day 2 rats) were plated into each well in SATO medium supplemented with
2% FCS. Test reagents were added as indicated in the text, and the co-cul-
tures were maintained for 18 h. The co-cultures were then fixed and stained
for GAP-43 expression, and the mean length of the longest neurite per cell
measured for 
 
 
 
120–150 neurons as described previously (Williams et al.,
1994a). For CB1receptor expression, cerebellar neurons were cultured over-
night in eight-chamber tissue culture slides precoated with poly-
 
L
 
-lysine (as
above) and 10 
 
 
 
g/ml laminin (in DME for 2 h at 37
 
 
 
C). The cultures were
fixed for 1 h with 4% PFA, and after blocking nonspecific binding sites with
PBS/0.5% gelatin for 30 min at RT, were incubated with 20 
 
 
 
g/ml of affinity-
purified rabbit antibodies against the CB1 receptor (CB11-A; Alpha Diag-
nostic International, Inc.) overnight at 4
 
 
 
C. All other steps in the staining
procedure were as described previously for GAP-43 (see above).
 
Materials
 
ACEA (arachidonyl-2¢-chloroethylamide 
 
N
 
-[2-chloroethyl]-5
 
Z
 
,8
 
Z
 
,11
 
Z
 
,14
 
Z
 
-
eicosatetraenamide), NA (2-arachidonylglycerol ether; 2-[(5
 
Z
 
,8
 
Z
 
,11
 
Z
 
,14
 
Z
 
)-
 
eicosatetraenyloxy]-1,3-propanediol), WIN 55,212–2 mesylate ((
 
R
 
)-(
 
 
 
)-
[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo-[1,2,3-de]-1,4-ben-
zoxazin-6-yl]-1-naphthalenylmethanone mesylate), AM 281 (1-(2,4-dichlo-
rophenyl)-5-(4-iodophenyl)-4-methyl-
 
N
 
-4-morpholinyl-1
 
H
 
-pyrazole-3-car-
boxamide) and AM 251 (
 
N
 
-[piperidin-1-yl]-5-[4-iodophenyl]-1-[2,4-
dichlorophenyl]-4-methyl-1
 
H
 
-pyrazole-3-carboxamide), and AM 630 (6-
Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1
 
H
 
-indol-3-yl](4-methoxyphenyl)
methanone) were obtained from Tocris Cookson, Ltd., and were used at
concentrations recommended by the supplier. BDNF and FGF2 were ob-
tained from R&D Systems. Arachidonic acid was obtained from Affinity
Bioreagents, Inc., and was used as described previously (Williams et al.,
1994c). Diltiazem hydrochloride was obtained from Calbiochem, and
 
 
 
-conotoxin GVIA was obtained from Alomone Labs; both were used as
described previously (Doherty et al., 1991a).
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